| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/06/2000 | WO2000038657A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | WO2000038656A1 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000038652A1 Polyol/oil suspensions for the sustained release of proteins |
| 07/06/2000 | WO2000038651A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
| 07/06/2000 | WO2000038650A1 Gastric retention dosage form having multiple layers |
| 07/06/2000 | WO2000038649A1 Pharmaceutical composition for oral administration designed to prevent misuse at the expense of a third party |
| 07/06/2000 | WO2000038647A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/06/2000 | WO2000038646A1 Dermatological compositions containing tannic acid and a microbial proliferation inhibitor |
| 07/06/2000 | WO2000038644A1 Stable solution of zinc ions and bicarbonate and/or carbonate ions |
| 07/06/2000 | WO2000038643A1 Oral hygiene product containing spherical microparticles on the basis of linear water-insoluble polyglucans |
| 07/06/2000 | WO2000038626A2 Substrate composition and method of use for sequestration of skin irritants |
| 07/06/2000 | WO2000038625A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 07/06/2000 | WO2000038620A2 A composition useful to treat periodontal disease |
| 07/06/2000 | WO2000018387A3 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/06/2000 | WO2000013686A3 Sustained release ranolazine formulations |
| 07/06/2000 | WO2000013476A3 A bubble drop and method of making same |
| 07/06/2000 | WO1999055286A3 Drug-containing transdermal patches, plastisols and adhesives |
| 07/06/2000 | WO1999054784A9 Free-form nanofabrication using multi-photon excitation |
| 07/06/2000 | DE19900054A1 Taxane enthaltende stabile und sterile Emulsion und Verfahren zu ihrer Herstellung Taxanes containing sterile and stable emulsion and process for their preparation |
| 07/06/2000 | DE19860698A1 Neue pharmazeutische Zusammensetzung New pharmaceutical composition |
| 07/06/2000 | DE19860373A1 Mundpflegemittel enthaltend shärische Mikropartikel auf Basis linearer wasserunlöslicher Polyglucane Oral care compositions comprising shärische microparticles based on linear water-insoluble polyglucans |
| 07/06/2000 | CA2362492A1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2357765A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/06/2000 | CA2356897A1 Apparatus and process for preparing crystalline particles |
| 07/06/2000 | CA2356895A1 Aciclovir compositions containing dimethicone |
| 07/06/2000 | CA2355891A1 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient |
| 07/06/2000 | CA2355872A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | CA2355271A1 Cyclosporin solution |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350685A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 07/06/2000 | CA2318356A1 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin |
| 07/05/2000 | EP1016673A1 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| 07/05/2000 | EP1016453A1 Nanoemulsion based on ethoxylated fatty ethers or ethoxylated fatty esters and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology |
| 07/05/2000 | EP1016417A1 Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters |
| 07/05/2000 | EP1016409A1 Freeze-dried composition containing glycosphingolipid and process for producing the same |
| 07/05/2000 | EP1016406A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
| 07/05/2000 | EP1016404A1 Aqueous preparation of beta-carotene |
| 07/05/2000 | EP1016403A2 Skin cleansing composition |
| 07/05/2000 | EP1015570A1 Fibrin microbeads and uses thereof |
| 07/05/2000 | EP1015470A1 Composition and method for delivery of nucleic acids |
| 07/05/2000 | EP1015465A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 07/05/2000 | EP1015448A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods |
| 07/05/2000 | EP1015225A2 Material having a substance protected by deformable standoffs and method of making |
| 07/05/2000 | EP1015106A1 Betaine product, method for its manufacture, and its use |
| 07/05/2000 | EP1015046A2 Microdisperse drug delivery systems |
| 07/05/2000 | EP1015039A1 Oxygen delivery agents and uses for the same |
| 07/05/2000 | EP1015032A2 High viscosity liquid controlled delivery system as a device |
| 07/05/2000 | EP1015031A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/05/2000 | EP1015022A1 New improved formulation for treatment of thromboembolism |
| 07/05/2000 | EP1015017A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015004A1 Pharmaceutical and alimentary compositions containing bacteria of the genus acetobacter |
| 07/05/2000 | EP1014997A1 Substance and method for reduction of lipids and cholesterol |
| 07/05/2000 | EP1014993A1 New use for budesonide and formoterol |
| 07/05/2000 | EP1014987A1 Oral compositions of levosimendan |
| 07/05/2000 | EP1014970A1 Parasiticidal formulations |
| 07/05/2000 | EP1014961A1 Improved treatment of migraine headache |
| 07/05/2000 | EP1014955A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 07/05/2000 | EP1014954A2 Transdermal therapeutic system |
| 07/05/2000 | EP1014953A2 Formulations for hydrophobic pharmaceutical agents |
| 07/05/2000 | EP1014952A1 Multiple unit effervescent dosage form |
| 07/05/2000 | EP1014951A1 Pharmaceutical coating composition and method of use |
| 07/05/2000 | EP1014950A1 Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof |
| 07/05/2000 | EP1014949A1 Rapidly disintegrating methylcellulose tablets |
| 07/05/2000 | EP1014948A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides |
| 07/05/2000 | EP1014947A1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 07/05/2000 | EP1014946A1 Sustained-release liposomal anesthetic compositions |
| 07/05/2000 | EP1014945A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/05/2000 | EP1014944A2 Biocompatible compounds for pharmaceutical drug delivery systems |
| 07/05/2000 | EP1014943A1 Medical aerosol formulations |
| 07/05/2000 | EP1014942A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin |
| 07/05/2000 | EP1014941A1 Hot-melt extrudable pharmaceutical formulation |
| 07/05/2000 | EP1014940A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 07/05/2000 | EP1014939A2 Encapsulation of water insoluble active substances with an amphiphilic character |
| 07/05/2000 | EP1014916A2 Foaming skin cream, uses thereof and a method for producing the same |
| 07/05/2000 | EP1014886A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 07/05/2000 | EP1014881A1 Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain |
| 07/05/2000 | EP1014812A1 Smoking products containing antioxidants |
| 07/05/2000 | EP1014805A1 Chewing gum containing physiological cooling agents |
| 07/05/2000 | EP1014787A1 Adjuvant for transcutaneous immunization |
| 07/05/2000 | EP0866874B1 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid |
| 07/05/2000 | EP0831923A4 Separation of active complexes |
| 07/05/2000 | EP0781122B1 Matrix for transdermal drug delivery |
| 07/05/2000 | EP0752877B1 Stabilized composition for oral administration of peptides |
| 07/05/2000 | EP0689461B1 Improvements in or relating to contrast agents |
| 07/05/2000 | CN1259142A Zinc free insulin crystals for use in pulmonary compositions |
| 07/05/2000 | CN1259134A Novel class of nucleic acid cationic transfecting agents |
| 07/05/2000 | CN1259048A Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 07/05/2000 | CN1259046A Selectively-activatible sheet material for dispensing and dispersing a substance onto a target surface |
| 07/05/2000 | CN1259045A Method for oral delivery of proteins |
| 07/05/2000 | CN1259044A A delivery system for an oral care substance using a strip of material having low flexural stiffness |
| 07/05/2000 | CN1259040A Compositions and methods for inhibiting photoaging of skin |
| 07/05/2000 | CN1259030A A transurethral device |
| 07/05/2000 | CN1259017A Non-spherical and non-platelet pyrithione salts |
| 07/05/2000 | CN1258532A Medicated cosmetics capable of being used to treat primary and secondary varicose vein simultaneously and its preparation |